CALGARY, ALBERTA--(Marketwire - April 10, 2012) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT" or the "Company") has provided a corporate update for its shareholders now available on the investors' page of the Company's website: www.stemcellthera.com.
The Company anticipates releasing its 2011 fourth quarter and year-end financial results on or about April 26, 2012, which will be followed by a conference call the next day, hosted by Mr. David Allan, Executive Chairman of Stem Cell Therapeutics. Mr. Allan will be available for a question and answer session after providing the corporate update. Conference call details will be confirmed in the 2011 year-end financial press release.
About Stem Cell Therapeutics Corp
Stem Cell Therapeutics is the only public Canadian company developing stem cell therapeutic technologies through partnerships with academic and research institutions across Canada and abroad. We intend to continue to use our extensive expertise and experience in the stem cell arena together with knowledge of the biotechnology sector and capital markets to both develop our existing pipeline of valuable intellectual property in regenerative medicine and also to expand the Company's interests by acquiring new early-stage clinical or late-stage developmental candidates initially in Canada and internationally.
For further information on Stem Cell Therapeutics Corp., visit www.stemcellthera.com
Caution Regarding Forward-Looking Information:
Certain statements contained in this press release constitute forward-looking information within the meaning of applicable Canadian provincial securities legislation (collectively, the "forward-looking statements"). These forward-looking statements relate to, among other things, SCT's objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, and can, in some cases, be identified by the use of words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from these expectations include, among other things: uncertainties and risks related to, the availability of capital, changes in capital markets, uncertainties related to clinical trials and product development, rapid technological change, uncertainties related to forecasts, competition, potential product liability, unproven markets for technologies in development, the cost and supply of raw materials, management of growth, effects of payors' willingness to pay for products, risks related to regulatory matters and risks related to intellectual property matters. Additional information about these factors and about the material factors or assumptions underlying such forward-looking statements may be found in the body of this news release, as well as under the heading "Risk Factors" contained in SCT's 2010 annual information form. SCT cautions that the foregoing list of important factors that may affect future results is not exhaustive.
When relying on SCT's forward-looking statements to make decisions with respect to SCT, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Such forward-looking statements are based on a number of estimates and assumptions which may prove to be incorrect, including, but not limited to, assumptions regarding the availability of financing for research and development companies in addition to general business and economic conditions. These risks and uncertainties should be considered carefully and investors and others should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, SCT cannot provide assurance that actual results will be consistent with these forward-looking statements. SCT undertakes no obligation to update or revise any forward-looking statement.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
David Allan
Executive Chairman
DAllan@StemCellThera.com
www.stemcellthera.com